HRG petition on Zelnorm
Executive Summary
FDA responded to Public Citizen Health Research Group's petition not to approve Novartis' irritable bowel syndrome therapy Zelnorm (tegaserod) on Nov. 6. "As Novartis announced in a press release dated June 18, 2001, FDA recently refused to approve Zelnorm," FDA noted. "Therefore, your petition is granted"...